September 22, 2022

Sasha Parikh, Angela Connell

Ken Schuler, Craig Arakawa

Division of Corporation Finance

Office of Life Sciences

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Re:    Albemarle Corporation

Form 10-K for Fiscal Year Ended December 31, 2021

Filed February 22, 2022

File No. 001-12658

Dear Ms. Parikh, Ms. Connell, Mr. Schuler and Mr. Arakawa:

In your letter dated September 14, 2022 (the “Staff Comment Letter”), you requested that we respond to your comments regarding our Form 10-K for fiscal year ended December 31, 2021 within ten business days or advise you when we would provide a response.

During our telephone conversation with you on September 22, 2022, we advised you that we would like to request an extension of time to provide a response in order to collect additional information to address certain disclosure requests. Accordingly, we respectfully request an extension until Wednesday, October 12, 2022 to file our response to the Staff Comment Letter.

Thank you for your consideration of our request for an extension. If you have any questions, please do not hesitate to contact Scott Tozier at (980) 299-5596.

Sincerely,

ALBEMARLE CORPORATION

/s/ SCOTT A. TOZIER

Scott A. Tozier

Executive Vice President, Chief Financial Officer